Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe

Research output: Contribution to journal › Review article › Contributed › peer-review

Contributors

  • Gudrun Goßrau - , Department of Anesthesiology and Intensive Care Medicine, University Comprehensive Pain Centre (Author)
  • Stefanie Förderreuther - , Ludwig Maximilian University of Munich (Author)
  • Ruth Ruscheweyh - , Ludwig Maximilian University of Munich, German Migraine and Headache Society, Technical University of Munich (Author)
  • Victoria Ruschil - , University of Tübingen (Author)
  • Till Sprenger - , DKD Helios Klinik Wiesbaden (Author)
  • David Lewis - , LEWIS Neurologie (Author)
  • Katharina Kamm - , Ludwig Maximilian University of Munich (Author)
  • Tobias Freilinger - , Hospital Passau (Author)
  • Lars Neeb - , Helios Hospital Group, Charité – Universitätsmedizin Berlin (Author)
  • Volker Malzacher - , Neurozentrum Reutlingen (Author)
  • Uwe Meier - , Berufsverband Deutscher Neurologen (Author)
  • Klaus Gehring - , Berufsverband Deutscher Nervenärzte (Author)
  • Torsten Kraya - , Klinikum St. Georg Leipzig, Martin Luther University Hospital (Author)
  • Thomas Dresler - , University of Tübingen (Author)
  • Christoph J. Schankin - , University of Bern (Author)
  • Andreas R. Gantenbein - , ZURZACH Care, Praxis Neurologie am Untertor (Author)
  • Gregor Brössner - , University of Innsbruck (Author)
  • Karin Zebenholzer - , Medical University of Vienna (Author)
  • Hans Christoph Diener - , University of Duisburg-Essen (Author)
  • Charly Gaul - , Kopfschmerzzentrum Frankfurt (Author)
  • Tim P. Jürgens - , University of Rostock, KMG Klinikum Güstrow (Author)

Abstract

Migraine is the most common neurological disorder and can be associated with a high degree of disability. In addition to non-pharmacological approaches to reduce migraine frequency, pharmacological migraine preventatives are available. Evidence-based guidelines from the German Migraine and Headache Society (DMKG), and German Society for Neurology (DGN), Austrian Headache Society (ÖKSG), and Swiss Headache Society (SKG) are available for indication and application. For therapy-relevant questions such as the duration of a pharmacological migraine prevention, no conclusions can be drawn from currently available study data. The aim of this review is to present a therapy consensus statement that integrates the current data situation and, where data are lacking, expert opinions. The resulting current recommendations on the duration of therapy for pharmacological migraine prophylaxis are shown here.

Translated title of the contribution
Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis

Details

Original languageGerman
Pages (from-to)306-317
Number of pages12
JournalNervenarzt
Volume94
Issue number4
Publication statusPublished - Apr 2023
Peer-reviewedYes

External IDs

PubMed 36287216

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • Migraine, Migraine disorder, Migraine headache, Migraine therapy, Therapy guideline

Library keywords